Case scenario: Increased end-tidal carbon dioxide: A diagnostic dilemma

Anesthesiology

Volumn 112, Issue 2, 2010, Pages 440-446

  Tautz, Timothy J ^a   Urwyler, Albert ^b   Antognini, Joseph F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; ANTIINFECTIVE AGENT;

ADULT; CARDIOPULMONARY FUNCTION; CASE REPORT; CLINICAL DECISION MAKING; CLINICAL EVALUATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; END TIDAL CARBON DIOXIDE TENSION; HUMAN; MALE; MALIGNANT HYPERTHERMIA; PATHOPHYSIOLOGY; PATIENT MONITORING; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; ABSCESS; ADDICTION; ANESTHESIA; ANESTHESIOLOGY; ARTICLE; EQUIPMENT; GENERAL ANESTHESIA; INSTRUMENTATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PEROPERATIVE CARE; WOUND DRAINAGE;

ABSCESS; ANESTHESIA; ANESTHESIA, GENERAL; ANESTHESIOLOGY; ANTI-BACTERIAL AGENTS; CARBON DIOXIDE; DRAINAGE; EQUIPMENT FAILURE; HUMANS; INTRAOPERATIVE CARE; MALE; MALIGNANT HYPERTHERMIA; MIDDLE AGED; MONITORING, INTRAOPERATIVE; POSTOPERATIVE CARE; SUBSTANCE-RELATED DISORDERS;

EID: 77449140706     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181ca7c38     Document Type: Article

References (27)

1. Gronert GA, Pessah IN, Muldoon SM, Tautz TJ: Malignant hyperthermia, Anesthesia, 6th edition. Edited by Miller RD. Philadelphia, Elsevier, 2005, pp 1169-1190
2. Ellett AE, Shields JC, Ifune C, Roa N, Vannucci A: A near miss: A nitrous oxide-carbon dioxide mix-up despite current safety standards. ANESTHESIOLOGY 2009; 110:1429-1431
3. Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, Kaplan RF, Muldoon SM, Nelson TE, Ording H: A clinical grading scale to predict malignant hyperthermia susceptibility. ANESTHESIOLOGY 1994; 80:771-779
4. Rosenberg H, Antognini JF, Muldoon S: Testing for malignant hyperthermia. ANESTHESIOLOGY 2002; 96:232-237
5. Burkman JM, Posner KL, Domino KB: Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions. ANESTHESIOLOGY 2007; 106: 901-906
6. Bosch X, Poch E, Grau JM: Rhabdomyolysis and acute kidney injury. N Engl J Med 2009; 361:62-72
7. Antognini JF: Creatine kinase alterations after acute malignant hyperthermia episodes and common surgical procedures. Anesth Analg 1995; 81:1039-1042
8. Rosero EB, Adesanya AO, Timaran CH, Joshi GP: Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005. ANESTHESIOLOGY 2009; 110:89-94
9. Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB: Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: A report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States. ANESTHESIOLOGY 2008; 108:603-611
10. Litman RS, Flood CD, Kaplan RF, Kim YL, Tobin JR: Postoperative malignant hyperthermia: An analysis of cases from the North American Malignant Hyperthermia Registry. ANESTHESIOLOGY 2008; 109:825-829
11. Allen GC, Larach MG, Kunselman AR: The sensitivity and specificity of the caffeine-halothane contracture test: A report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS. ANESTHESIOLOGY 1998; 88:579-588
12. Rosenberg H, Davis M, James D, Pollock N, Stowell K: Malignant hyperthermia. Orphanet J Rare Dis 2007; 2:21
13. Carpenter D, Robinson RL, Quinnell RJ, Ringrose C, Hogg M, Casson F, Booms P, Iles DE, Halsall PJ, Steele DS, Shaw MA, Hopkins PM: Genetic variation in RYR1 and malignant hyperthermia phenotypes. Br J Anaesth 2009; 103:538-548
14. Gronert GA, Milde JH: Variations in onset of porcine malignant hyperthermia. Anesth Analg 1981; 60:499-503
15. Davis PJ, Brandom BW: The association of malignant hy-perthermia and unusual disease: When you're hot you're hot or maybe not. Anesth Analg 2009; 109:1001-1003
16. Brandom BW: Genetics of malignant hyperthermia. Scien-tificWorldJournal 2006; 6:1722-1730
17. Monnier N, Procaccio V, Stieglitz P, Lunardi J: Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sen-sitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 1997; 60:1316-1325
18. Protasi F, Paolini C, Dainese M: Calsequestrin-1: A new candidate gene for malignant hyperthermia (MH) and ex-ertional/environmental heat stroke (EHS). J Physiol (London) 2009; 587:3095-3100
19. Kalow W, Britt BA, Terreau ME, Haist C: Metabolic error of muscle metabolism after recovery from malignant hyper-thermia. Lancet 1970; 2:895-898
20. Ellis FR, Harriman DG, Keaney NP, Kyei-Mensah K, Tyrrell JH: Halothane-induced muscle contracture as a cause of hyperpyrexia. Br J Anaesth 1971; 43:721-722
21. Fletcher JE, Conti PA, Rosenberg H: Comparison of North American and European malignant hyperthermia group halothane contracture testing protocols in swine. Acta Anaesthesiol Scand 1991; 35:483-487
22. Urwyler A, Deufel T, McCarthy T, West S: Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 2001; 86:283-287
23. Schuster F, Metterlein T, Negele S, Kranke P, Muellenbach RM, Schwemmer U, Roewer N, Anetseder M: An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: A pilot study. Anesth Analg 2008; 107:909-914
24. Anderson AA, Brown RL, Polster B, Pollock N, Stowell KM: Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia. ANESTHESIOLOGY 2008; 108:208-215
25. Benca J, Hogan K: Malignant hyperthermia, coexisting disorders, and enzymopathies: Risks and management options. Anesth Analg 2009; 109:1049-1053
26. Gurnaney H, Brown A, Litman RS: Malignant hyperthermia and muscular dystrophies. Anesth Analg 2009; 109:1043-1048
27. Capacchione JF, Muldoon SM: The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia. Anesth Analg 2009; 109:1065-1069